Further Decision Processed by IB
05/03/2025
Back to search
Official data from USPTO
KRENAVA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
05/04/2025
Trademark type
Word
Nice classes
5
Filing date
10/21/2015
Registration date
06/07/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/23/2022
Last transaction
05/04/2025
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
CH
Examiner
GARTNER, JOHN
Law office
L20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Novartis AG
Representatives
Novartis Pharma AG, Trademark Department
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous systemthe immune systemthe cardiovascular systemthe metabolic systemthe endocrine systemthe respiratory systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatologyoncologyhematology and in tissue and organ transplantationin ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteriaautoimmune diseases and disorderskidney diseases and disordersdiabetes; antifungalanti-infectiveantiviral preparations and antibiotics
Publications
History of USPTO decisions and trademark events.
20 publications found
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
03/21/2025
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
03/21/2025
XXCR
GENERIC MADRID TRANSACTION CREATED
03/21/2025
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
08/23/2023
C71T
CANCELLED SECTION 71
12/23/2022
RNWL
INTERNATIONAL REGISTRATION RENEWED
01/26/2017
GPNX
NOTIFICATION PROCESSED BY IB
12/09/2016
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/08/2016
FIMP
FINAL DISPOSITION PROCESSED
07/08/2016
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
07/07/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
06/07/2016
PUBO
PUBLISHED FOR OPPOSITION
03/22/2016
NPUB
NOTICE OF PUBLICATION
03/02/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/05/2016
DOCK
ASSIGNED TO EXAMINER
02/05/2016
MAFR
APPLICATION FILING RECEIPT MAILED
02/02/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/28/2016
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
01/22/2016
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
01/21/2016
Continuous trademark protection
Get notified about every new filing that threatens KRENAVA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.